U.S. flag

An official website of the United States government

NM_000048.4(ASL):c.348+1G>T AND Argininosuccinate lyase deficiency

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Aug 27, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002013281.4

Allele description [Variation Report for NM_000048.4(ASL):c.348+1G>T]

NM_000048.4(ASL):c.348+1G>T

Gene:
ASL:argininosuccinate lyase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q11.21
Genomic location:
Preferred name:
NM_000048.4(ASL):c.348+1G>T
HGVS:
  • NC_000007.14:g.66082937G>T
  • NG_009288.1:g.12149G>T
  • NM_000048.4:c.348+1G>TMANE SELECT
  • NM_001024943.2:c.348+1G>T
  • NM_001024944.2:c.348+1G>T
  • NM_001024946.2:c.348+1G>T
  • NC_000007.13:g.65547924G>T
Links:
dbSNP: rs2115698756
NCBI 1000 Genomes Browser:
rs2115698756
Molecular consequence:
  • NM_000048.4:c.348+1G>T - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001024943.2:c.348+1G>T - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001024944.2:c.348+1G>T - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001024946.2:c.348+1G>T - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
Argininosuccinate lyase deficiency
Synonyms:
Arginino succinase deficiency; Inborn error of urea synthesis, arginino succinic type; Urea cycle disorder, arginino succinase type; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008815; MedGen: C0268547; Orphanet: 23; OMIM: 207900; Human Phenotype Ontology: HP:0025630

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002295768Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Aug 27, 2021)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Expanding the phenotype in argininosuccinic aciduria: need for new therapies.

Baruteau J, Jameson E, Morris AA, Chakrapani A, Santra S, Vijay S, Kocadag H, Beesley CE, Grunewald S, Murphy E, Cleary M, Mundy H, Abulhoul L, Broomfield A, Lachmann R, Rahman Y, Robinson PH, MacPherson L, Foster K, Chong WK, Ridout DA, Bounford KM, et al.

J Inherit Metab Dis. 2017 May;40(3):357-368. doi: 10.1007/s10545-017-0022-x. Epub 2017 Mar 1.

PubMed [citation]
PMID:
28251416
PMCID:
PMC5393288

Splicing in action: assessing disease causing sequence changes.

Baralle D, Baralle M.

J Med Genet. 2005 Oct;42(10):737-48. Review.

PubMed [citation]
PMID:
16199547
PMCID:
PMC1735933
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002295768.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Disruption of this splice site has been observed in individual(s) with argininosuccinate lyase deficiency (PMID: 28251416). This variant is not present in population databases (ExAC no frequency). This sequence change affects a donor splice site in intron 5 of the ASL gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ASL are known to be pathogenic (PMID: 2263616, 24166829).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024